Biomerica Receives Notice of Allowance for Irritable Bowel Syndrome (IBS) Test Panel and Methods in Korea Medical Device Investing
Naturally Splendid’s President and Co-Founder Presents Investor Roadshow at Cannabis Online Investment Conference Cannabis Investing News
XELJANZ (tofacitinib citrate) Receives Marketing Authorization in the European Union for Moderately to Severely Active Ulcerative Colitis Pharmaceutical Investing
Cellectar and Orano Med Announce Collaboration to Develop New Phospholipid Drug Conjugate Biotech Investing
Neuralstem Announces Initiation of Phase 2 Clinical Trial of NSI-189 in Ischemic Stroke Biotech Investing
